Paediatric antiretroviral use

Prezista (darunavir) has had its licence extended to include use in the treatment of HIV in antiretroviral-experienced children and adolescents over six years and weighing at least 20kg. Prezista should always be given in combination with low-dose ritonavir and other antiretrovirals.

View Prezista drug record

Further information: Janssen-Cilag

In addition, Aptivus (tipranavir) is now licensed for the treatment of HIV in highly pre-treated adolescents 12 years of age or older with virus resistant to multiple protease inhibitors. The drug should only be used as part of an active combination antiretroviral regimen in patients with no other therapeutic options.

View Aptivus drug record

Further information: Boehringer Ingelheim

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Added: fludroxycortide, levofloxacin, Noriday, Ongentys...

Vaping still safer than smoking, say health bosses after report of severe lung injury
Free online vestibular rehabilitation tool 'highly effective' for vertigo symptoms

Free online vestibular rehabilitation tool 'highly effective' for vertigo symptoms

GPs should consider online vestibular rehabilitation...

Thiazides better than ACE inhibitors as first-line antihypertensives, large-scale analysis suggests